跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MAR-ACARBOSE
Authorized
STANDARD
MAR-ACARBOSE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4d3494a5ebd75e1c
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
4d3494a5ebd75e1c
Drug Approval Canada Name
MAR-ACARBOSE
Product Name
MAR-ACARBOSE
Status
Marketed
Status Date
2020-02-05
Original Market Date
2020-02-05
Din
02494078
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.02
Atc Original
A10BF01 ACARBOSE
Atc Name
a 10 bf 01
Aig Number
0123099002
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
ACARBOSE
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4d3494a5ebd75e1c
Type
Standard
Back to Health Canada Approvals
MAR-ACARBOSE - Health Canada Drug Approval Details